tiprankstipranks
TC Biopharm Faces Potential Nasdaq Delisting Due to Bid Price Non-Compliance
Company Announcements

TC Biopharm Faces Potential Nasdaq Delisting Due to Bid Price Non-Compliance

Story Highlights

Stay Ahead of the Market:

TC Biopharm (Holdings) Plc Sponsored ADR ( (TCBP) ) has provided an announcement.

TC Biopharm (Holdings) Plc announced that it received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement, leading to a possible delisting of its securities. The company intends to request a hearing to maintain its listing on the Nasdaq Capital Market, although it remains uncertain if the extension will be granted or if compliance can be achieved within the given timeframe.

More about TC Biopharm (Holdings) Plc Sponsored ADR

TC Biopharm (Holdings) Plc is a company operating within the biotechnology sector, focusing primarily on developing innovative cell therapies aimed at treating cancer and other conditions. The company is based in Scotland, United Kingdom, and has been working to establish a strong presence in the biotech market.

YTD Price Performance: -21.41%

Average Trading Volume: 1,888,547

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $199.2K

Find detailed analytics on TCBP stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App